This site is intended for healthcare professionals only
LoginRegister
Indias landmark Dengue Vaccine trial enrolment to wrap up by October: ICMROne-shot Dengue vaccine 'DengiAll' completes 70% enrolment of participants in Phase III trial:...
Sun PharmaSun Pharma Gets Relief As Delhi HC Bars Use of BERIVITAL, BEZOLIC, DOZE-30 For Trademark...
Sanores Pharma appoints Sanjay Moralwar as Head of ITSenores Pharma appoints Sanjay Moralwar as Head of IT
CDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in IndiaCDSCO Panel Recommends Approval for Vorasidenib with Phase-III Waiver, Mandates Phase-IV Trial in...
Sanofi Commits USD 625 Million to Sanofi Ventures to Boost Biotech and Digital Health StartupsSIL declares profit from operations growth as +6% vs previous year
Novartis Loses India Patent on Heart Failure Drug VymadaNovartis Told to Revise Protocol, Justify Sample Size in ITU512 Clinical Trial Proposal
Mandatory Excipients Disclosure on Drug Labels from March 2026: Health MinistryHealth Ministry Notifies Cosmetics Rules 2025, Empowers States To Suspend Licences
Nasal SprayBiodeal Told To Justify Novel Delivery Claim In NPPA Exemption Plea For Midazolam Nasal Spray
Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial ProtocolCDSCO Panel Accepts Phase I Trial Data for Intas' Denosumab Biosimilar
Torrent Pharma Slapped Rs 60.28 Lakh NPPA Notice for Alleged OverchargingTorrent Pharma: USFDA concludes inspection at Vizag facility with zero observations
Gilead Sciences gets USFDA nod for new Biktarvy indicationGilead Sciences gets USFDA nod for new Biktarvy indication for people with HIV who are treatment...
Jubilant Generics Roorkee facilityUSFDA issues 4 observations for Jubilant Generics Roorkee facility
X